| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GB:CTEC
ConvaTec
|
Jun 08, 2026 | BUY |
Strong Buy
+41.3% avg upside
16 analysts
|
$300.00
45.12% Upside
|
· |
|
IT:AMP
Amplifon S.p.A.
|
May 15, 2026 | HOLD |
Hold
+155.3% avg upside
12 analysts
|
$11.00
6.47% Upside
|
· |
|
DE:SHL
Siemens Healthineers AG
|
May 14, 2026 | BUY |
Strong Buy
+51.7% avg upside
22 analysts
|
$50.00
46.42% Upside
|
· |
|
NL:PHIA
Koninklijke Philips N.V.
|
May 14, 2026 | HOLD |
Buy
+31.4% avg upside
20 analysts
|
$25.00
6.94% Upside
|
· |
|
FR:EL
EssilorLuxottica SA
|
Apr 22, 2026 | BUY |
Strong Buy
+12.7% avg upside
17 analysts
|
$300.00
72.83% Upside
|
· |
|
GB:0K9P
GN Store Nord
|
Mar 18, 2026 | HOLD |
Hold
+169.4% avg upside
13 analysts
|
$111.00
25.26% Upside
|
· |
|
CH:STMN
Straumann Holding AG
|
Feb 19, 2026 | HOLD |
Buy
+19.9% avg upside
13 analysts
|
$110.00
4.84% Upside
|
· |
|
CH:SOON
Sonova Holding AG
|
Sep 30, 2025 | HOLD |
Sell
+14.3% avg upside
17 analysts
|
$235.00
22.36% Upside
|
· |
|
GB:0QBO
Coloplast A/S
|
Aug 20, 2025 | BUY |
Buy
+87.4% avg upside
16 analysts
|
$800.00
114.30% Upside
|
· |
|
GB:SN
Smith & Nephew
|
Aug 06, 2025 | BUY |
Strong Buy
+1305.8% avg upside
15 analysts
|
$1500.00
32.67% Upside
|
· |
|
WILLF
Demant
|
Feb 06, 2025 | HOLD |
Buy
+10.7% avg upside
19 analysts
|
$41.17
16.13% Upside
|
-6.3% |
|
PHG
Koninklijke Philips
|
Nov 29, 2024 | HOLD |
Buy
+31.4% avg upside
13 analysts
|
$26.40
1.35% Downside
|
+7.5% |
|
SE:EKTA.B
Elekta AB
|
Nov 30, 2023 | HOLD |
Sell
+23.4% avg upside
12 analysts
|
$85.00
75.17% Upside
|
· |
|
DE:FME
Fresenius Medical Care AG & Co. KGaA
|
Jun 05, 2020 | BUY |
Buy
+27.6% avg upside
21 analysts
|
— | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.